CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
OSL:CONTX - Euronext Oslo - SE0014731154 - Common Stock - Currency: NOK
We assign a fundamental rating of 7 out of 10 to CONTX. CONTX was compared to 13 industry peers in the Health Care Technology industry. CONTX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CONTX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make CONTX suitable for value investing!
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
CONTX has a Return On Assets of 18.95%. This is amongst the best in the industry. CONTX outperforms 100.00% of its industry peers.
The Return On Equity of CONTX (26.19%) is better than 92.31% of its industry peers.
CONTX has a Return On Invested Capital of 23.11%. This is amongst the best in the industry. CONTX outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 9.30%.
The last Return On Invested Capital (23.11%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.95% | ||
| ROE | 26.19% | ||
| ROIC | 23.11% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a Profit Margin of 18.89%. This is in the better half of the industry: CONTX outperforms 76.92% of its industry peers.
In the last couple of years the Profit Margin of CONTX has grown nicely.
CONTX has a better Operating Margin (22.82%) than 92.31% of its industry peers.
In the last couple of years the Operating Margin of CONTX has grown nicely.
CONTX has a Gross Margin of 97.44%. This is amongst the best in the industry. CONTX outperforms 92.31% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.82% | ||
| PM (TTM) | 18.89% | ||
| GM | 97.44% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
CONTX has a debt to FCF ratio of 0.36. This is a very positive value and a sign of high solvency as it would only need 0.36 years to pay back of all of its debts.
CONTX has a Debt to FCF ratio of 0.36. This is amongst the best in the industry. CONTX outperforms 84.62% of its industry peers.
CONTX has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.08, CONTX is doing good in the industry, outperforming 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.36 | ||
| Altman-Z | N/A |
ROIC/WACC3.23
WACC7.15%
2.3 Liquidity
CONTX has a Current Ratio of 3.81. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX has a better Current ratio (3.81) than 92.31% of its industry peers.
A Quick Ratio of 3.78 indicates that CONTX has no problem at all paying its short term obligations.
CONTX has a better Quick ratio (3.78) than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.85%.
The Earnings Per Share has been growing by 27.25% on average over the past years. This is a very strong growth
The Revenue has decreased by -1.04% in the past year.
CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-24.85%
EPS 3YN/A
EPS 5Y27.25%
EPS Q2Q%85.65%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%2.82%
3.2 Future
CONTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.49% yearly.
Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 5.99% on average per year.
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue Next Year7.03%
Revenue Next 2Y6.07%
Revenue Next 3Y7.04%
Revenue Next 5Y5.99%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.01 indicates a rather expensive valuation of CONTX.
CONTX's Price/Earnings ratio is rather cheap when compared to the industry. CONTX is cheaper than 84.62% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.78, CONTX is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.48, which indicates a correct valuation of CONTX.
76.92% of the companies in the same industry are more expensive than CONTX, based on the Price/Forward Earnings ratio.
CONTX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.01 | ||
| Fwd PE | 13.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CONTX is valued a bit cheaper than 61.54% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CONTX is valued cheaper than 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.03 | ||
| EV/EBITDA | 9.77 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CONTX may justify a higher PE ratio.
CONTX's earnings are expected to grow with 21.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)0.66
EPS Next 2Y24.57%
EPS Next 3Y21.49%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
Compared to an average industry Dividend Yield of 4.06, CONTX pays a bit more dividend than its industry peers.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
OSL:CONTX (4/28/2025, 11:48:24 AM)
6.125
+0.01 (+0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners15.98%
Inst Owner ChangeN/A
Ins Owners25.32%
Ins Owner ChangeN/A
Market Cap473.89M
Analysts40
Price Target7.14 (16.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)7.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.01 | ||
| Fwd PE | 13.48 | ||
| P/S | 3.37 | ||
| P/FCF | 15.03 | ||
| P/OCF | 13.37 | ||
| P/B | 4.67 | ||
| P/tB | 4.86 | ||
| EV/EBITDA | 9.77 |
EPS(TTM)0.34
EY5.55%
EPS(NY)0.45
Fwd EY7.42%
FCF(TTM)0.41
FCFY6.65%
OCF(TTM)0.46
OCFY7.48%
SpS1.82
BVpS1.31
TBVpS1.26
PEG (NY)0.44
PEG (5Y)0.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.95% | ||
| ROE | 26.19% | ||
| ROCE | 29.25% | ||
| ROIC | 23.11% | ||
| ROICexc | 85.47% | ||
| ROICexgc | 98.32% | ||
| OM | 22.82% | ||
| PM (TTM) | 18.89% | ||
| GM | 97.44% | ||
| FCFM | 22.41% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.39%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.36 | ||
| Debt/EBITDA | 0.19 | ||
| Cap/Depr | 42.29% | ||
| Cap/Sales | 2.79% | ||
| Interest Coverage | 146.18 | ||
| Cash Conversion | 85.65% | ||
| Profit Quality | 118.61% | ||
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | N/A |
F-Score5
WACC7.15%
ROIC/WACC3.23
Cap/Depr(3y)35.71%
Cap/Depr(5y)46.79%
Cap/Sales(3y)2.5%
Cap/Sales(5y)4.26%
Profit Quality(3y)108.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.85%
EPS 3YN/A
EPS 5Y27.25%
EPS Q2Q%85.65%
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%2.82%
Revenue Next Year7.03%
Revenue Next 2Y6.07%
Revenue Next 3Y7.04%
Revenue Next 5Y5.99%
EBIT growth 1Y-25.52%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year71.07%
EBIT Next 3Y27.47%
EBIT Next 5YN/A
FCF growth 1Y-33.34%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-26.4%
OCF growth 3Y51.49%
OCF growth 5Y5.6%